U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.9875C>T (p.Pro3292Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Dec 13, 2021
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000131346.21

Allele description [Variation Report for NM_000059.4(BRCA2):c.9875C>T (p.Pro3292Leu)]

NM_000059.4(BRCA2):c.9875C>T (p.Pro3292Leu)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.9875C>T (p.Pro3292Leu)
Other names:
p.P3292L:CCG>CTG; NP_000050.3:p.Pro3292Leu
HGVS:
  • NC_000013.11:g.32398388C>T
  • NG_012772.3:g.87909C>T
  • NM_000059.4:c.9875C>TMANE SELECT
  • NP_000050.2:p.Pro3292Leu
  • NP_000050.3:p.Pro3292Leu
  • LRG_293t1:c.9875C>T
  • LRG_293:g.87909C>T
  • LRG_293p1:p.Pro3292Leu
  • NC_000013.10:g.32972525C>T
  • NM_000059.3:c.9875C>T
  • NM_000059.4:c.9875C>T
  • U43746.1:n.10103C>T
  • p.P3292L
Nucleotide change:
10103C>T
Protein change:
P3292L
Links:
dbSNP: rs56121817
NCBI 1000 Genomes Browser:
rs56121817
Molecular consequence:
  • NM_000059.4:c.9875C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000186321Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Benign
(Mar 4, 2021)
germlineclinical testing

PubMed (15)
[See all records that cite these PMIDs]

Citation Link,

SCV000902771Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(May 30, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002532067Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Dec 13, 2021)
germlinecuration

PubMed (13)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC.

Nature. 2005 Mar 31;434(7033):598-604.

PubMed [citation]
PMID:
15800615

The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry.

Ayoub N, Rajendra E, Su X, Jeyasekharan AD, Mahen R, Venkitaraman AR.

Curr Biol. 2009 Jul 14;19(13):1075-85. doi: 10.1016/j.cub.2009.05.057. Epub 2009 Jun 18.

PubMed [citation]
PMID:
19540122
PMCID:
PMC2719694
See all PubMed Citations (20)

Details of each submission

From Ambry Genetics, SCV000186321.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (15)

Description

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000902771.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002532067.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (13)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024